0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Digestive System Antacids Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24T19051
Home | Market Reports | Health| Health Conditions
Global Digestive System Antacids Market Research Report 2025
BUY CHAPTERS

Global Digestive System Antacids Market Research Report 2025

Code: QYRE-Auto-24T19051
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Digestive System Antacids Market Size

The global market for Digestive System Antacids was valued at US$ 845 million in the year 2024 and is projected to reach a revised size of US$ 1081 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Digestive System Antacids Market

Digestive System Antacids Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Digestive System Antacids competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Digestive system antacids are a class of medications that neutralize stomach acid to relieve symptoms caused by excessive gastric acidity, such as heartburn, indigestion, and acid reflux. They work by chemically buffering the acid in the stomach, thereby reducing irritation of the gastric lining and providing symptomatic relief in conditions like gastritis, peptic ulcers, and gastroesophageal reflux disease (GERD).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Digestive System Antacids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digestive System Antacids.
The Digestive System Antacids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digestive System Antacids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digestive System Antacids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Digestive System Antacids Market Report

Report Metric Details
Report Name Digestive System Antacids Market
Accounted market size in year US$ 845 million
Forecasted market size in 2031 US$ 1081 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Sodium Bicarbonate Tablets
  • Magnesium Aluminum Carbonate Tablets
  • Compound Aluminum Hydroxide Tablets
  • Aluminum Phosphate Gel
  • Other
Segment by Application
  • OTC Drug
  • Rx Drug
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter&Gamble, GlaxoSmithKline, Johnson&Johnson, CONBA, Huasen Pharma, Sanofi, Bausch Health, CR SANJIU, Reddy'sLaboratories, Almirall
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Digestive System Antacids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Digestive System Antacids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Digestive System Antacids Market growing?

Ans: The Digestive System Antacids Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Digestive System Antacids Market size in 2031?

Ans: The Digestive System Antacids Market size in 2031 will be US$ 1081 million.

Who are the main players in the Digestive System Antacids Market report?

Ans: The main players in the Digestive System Antacids Market are AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter&Gamble, GlaxoSmithKline, Johnson&Johnson, CONBA, Huasen Pharma, Sanofi, Bausch Health, CR SANJIU, Reddy'sLaboratories, Almirall

What are the Application segmentation covered in the Digestive System Antacids Market report?

Ans: The Applications covered in the Digestive System Antacids Market report are OTC Drug, Rx Drug

What are the Type segmentation covered in the Digestive System Antacids Market report?

Ans: The Types covered in the Digestive System Antacids Market report are Sodium Bicarbonate Tablets, Magnesium Aluminum Carbonate Tablets, Compound Aluminum Hydroxide Tablets, Aluminum Phosphate Gel, Other

1 Digestive System Antacids Market Overview
1.1 Product Definition
1.2 Digestive System Antacids by Type
1.2.1 Global Digestive System Antacids Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sodium Bicarbonate Tablets
1.2.3 Magnesium Aluminum Carbonate Tablets
1.2.4 Compound Aluminum Hydroxide Tablets
1.2.5 Aluminum Phosphate Gel
1.2.6 Other
1.3 Digestive System Antacids by Application
1.3.1 Global Digestive System Antacids Market Value by Application (2024 VS 2031)
1.3.2 OTC Drug
1.3.3 Rx Drug
1.4 Global Digestive System Antacids Market Size Estimates and Forecasts
1.4.1 Global Digestive System Antacids Revenue 2020-2031
1.4.2 Global Digestive System Antacids Sales 2020-2031
1.4.3 Global Digestive System Antacids Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Digestive System Antacids Market Competition by Manufacturers
2.1 Global Digestive System Antacids Sales Market Share by Manufacturers (2020-2025)
2.2 Global Digestive System Antacids Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Digestive System Antacids Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Digestive System Antacids, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Digestive System Antacids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Digestive System Antacids, Product Type & Application
2.7 Global Key Manufacturers of Digestive System Antacids, Date of Enter into This Industry
2.8 Global Digestive System Antacids Market Competitive Situation and Trends
2.8.1 Global Digestive System Antacids Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Digestive System Antacids Players Market Share by Revenue
2.8.3 Global Digestive System Antacids Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Digestive System Antacids Market Scenario by Region
3.1 Global Digestive System Antacids Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Digestive System Antacids Sales by Region: 2020-2031
3.2.1 Global Digestive System Antacids Sales by Region: 2020-2025
3.2.2 Global Digestive System Antacids Sales by Region: 2026-2031
3.3 Global Digestive System Antacids Revenue by Region: 2020-2031
3.3.1 Global Digestive System Antacids Revenue by Region: 2020-2025
3.3.2 Global Digestive System Antacids Revenue by Region: 2026-2031
3.4 North America Digestive System Antacids Market Facts & Figures by Country
3.4.1 North America Digestive System Antacids Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Digestive System Antacids Sales by Country (2020-2031)
3.4.3 North America Digestive System Antacids Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Digestive System Antacids Market Facts & Figures by Country
3.5.1 Europe Digestive System Antacids Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Digestive System Antacids Sales by Country (2020-2031)
3.5.3 Europe Digestive System Antacids Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Digestive System Antacids Market Facts & Figures by Region
3.6.1 Asia Pacific Digestive System Antacids Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Digestive System Antacids Sales by Region (2020-2031)
3.6.3 Asia Pacific Digestive System Antacids Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Digestive System Antacids Market Facts & Figures by Country
3.7.1 Latin America Digestive System Antacids Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Digestive System Antacids Sales by Country (2020-2031)
3.7.3 Latin America Digestive System Antacids Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Digestive System Antacids Market Facts & Figures by Country
3.8.1 Middle East and Africa Digestive System Antacids Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Digestive System Antacids Sales by Country (2020-2031)
3.8.3 Middle East and Africa Digestive System Antacids Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Digestive System Antacids Sales by Type (2020-2031)
4.1.1 Global Digestive System Antacids Sales by Type (2020-2025)
4.1.2 Global Digestive System Antacids Sales by Type (2026-2031)
4.1.3 Global Digestive System Antacids Sales Market Share by Type (2020-2031)
4.2 Global Digestive System Antacids Revenue by Type (2020-2031)
4.2.1 Global Digestive System Antacids Revenue by Type (2020-2025)
4.2.2 Global Digestive System Antacids Revenue by Type (2026-2031)
4.2.3 Global Digestive System Antacids Revenue Market Share by Type (2020-2031)
4.3 Global Digestive System Antacids Price by Type (2020-2031)
5 Segment by Application
5.1 Global Digestive System Antacids Sales by Application (2020-2031)
5.1.1 Global Digestive System Antacids Sales by Application (2020-2025)
5.1.2 Global Digestive System Antacids Sales by Application (2026-2031)
5.1.3 Global Digestive System Antacids Sales Market Share by Application (2020-2031)
5.2 Global Digestive System Antacids Revenue by Application (2020-2031)
5.2.1 Global Digestive System Antacids Revenue by Application (2020-2025)
5.2.2 Global Digestive System Antacids Revenue by Application (2026-2031)
5.2.3 Global Digestive System Antacids Revenue Market Share by Application (2020-2031)
5.3 Global Digestive System Antacids Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Digestive System Antacids Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Takeda Pharmaceutical
6.2.1 Takeda Pharmaceutical Company Information
6.2.2 Takeda Pharmaceutical Description and Business Overview
6.2.3 Takeda Pharmaceutical Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Pharmaceutical Digestive System Antacids Product Portfolio
6.2.5 Takeda Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Digestive System Antacids Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Reckitt Benckiser
6.4.1 Reckitt Benckiser Company Information
6.4.2 Reckitt Benckiser Description and Business Overview
6.4.3 Reckitt Benckiser Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Reckitt Benckiser Digestive System Antacids Product Portfolio
6.4.5 Reckitt Benckiser Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Digestive System Antacids Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Procter&Gamble
6.6.1 Procter&Gamble Company Information
6.6.2 Procter&Gamble Description and Business Overview
6.6.3 Procter&Gamble Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Procter&Gamble Digestive System Antacids Product Portfolio
6.6.5 Procter&Gamble Recent Developments/Updates
6.7 GlaxoSmithKline
6.7.1 GlaxoSmithKline Company Information
6.7.2 GlaxoSmithKline Description and Business Overview
6.7.3 GlaxoSmithKline Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline Digestive System Antacids Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Johnson&Johnson
6.8.1 Johnson&Johnson Company Information
6.8.2 Johnson&Johnson Description and Business Overview
6.8.3 Johnson&Johnson Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Johnson&Johnson Digestive System Antacids Product Portfolio
6.8.5 Johnson&Johnson Recent Developments/Updates
6.9 CONBA
6.9.1 CONBA Company Information
6.9.2 CONBA Description and Business Overview
6.9.3 CONBA Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CONBA Digestive System Antacids Product Portfolio
6.9.5 CONBA Recent Developments/Updates
6.10 Huasen Pharma
6.10.1 Huasen Pharma Company Information
6.10.2 Huasen Pharma Description and Business Overview
6.10.3 Huasen Pharma Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huasen Pharma Digestive System Antacids Product Portfolio
6.10.5 Huasen Pharma Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Digestive System Antacids Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Bausch Health
6.12.1 Bausch Health Company Information
6.12.2 Bausch Health Description and Business Overview
6.12.3 Bausch Health Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bausch Health Digestive System Antacids Product Portfolio
6.12.5 Bausch Health Recent Developments/Updates
6.13 CR SANJIU
6.13.1 CR SANJIU Company Information
6.13.2 CR SANJIU Description and Business Overview
6.13.3 CR SANJIU Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CR SANJIU Digestive System Antacids Product Portfolio
6.13.5 CR SANJIU Recent Developments/Updates
6.14 Reddy'sLaboratories
6.14.1 Reddy'sLaboratories Company Information
6.14.2 Reddy'sLaboratories Description and Business Overview
6.14.3 Reddy'sLaboratories Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Reddy'sLaboratories Digestive System Antacids Product Portfolio
6.14.5 Reddy'sLaboratories Recent Developments/Updates
6.15 Almirall
6.15.1 Almirall Company Information
6.15.2 Almirall Description and Business Overview
6.15.3 Almirall Digestive System Antacids Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Almirall Digestive System Antacids Product Portfolio
6.15.5 Almirall Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Digestive System Antacids Industry Chain Analysis
7.2 Digestive System Antacids Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Digestive System Antacids Production Mode & Process Analysis
7.4 Digestive System Antacids Sales and Marketing
7.4.1 Digestive System Antacids Sales Channels
7.4.2 Digestive System Antacids Distributors
7.5 Digestive System Antacids Customer Analysis
8 Digestive System Antacids Market Dynamics
8.1 Digestive System Antacids Industry Trends
8.2 Digestive System Antacids Market Drivers
8.3 Digestive System Antacids Market Challenges
8.4 Digestive System Antacids Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Digestive System Antacids Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Digestive System Antacids Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Digestive System Antacids Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Digestive System Antacids Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Digestive System Antacids Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Digestive System Antacids Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Digestive System Antacids Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Digestive System Antacids Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Digestive System Antacids, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Digestive System Antacids, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Digestive System Antacids, Product Type & Application
 Table 12. Global Key Manufacturers of Digestive System Antacids, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Digestive System Antacids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digestive System Antacids as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Digestive System Antacids Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Digestive System Antacids Sales by Region (2020-2025) & (K Units)
 Table 18. Global Digestive System Antacids Sales Market Share by Region (2020-2025)
 Table 19. Global Digestive System Antacids Sales by Region (2026-2031) & (K Units)
 Table 20. Global Digestive System Antacids Sales Market Share by Region (2026-2031)
 Table 21. Global Digestive System Antacids Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Digestive System Antacids Revenue Market Share by Region (2020-2025)
 Table 23. Global Digestive System Antacids Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Digestive System Antacids Revenue Market Share by Region (2026-2031)
 Table 25. North America Digestive System Antacids Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Digestive System Antacids Sales by Country (2020-2025) & (K Units)
 Table 27. North America Digestive System Antacids Sales by Country (2026-2031) & (K Units)
 Table 28. North America Digestive System Antacids Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Digestive System Antacids Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Digestive System Antacids Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Digestive System Antacids Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Digestive System Antacids Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Digestive System Antacids Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Digestive System Antacids Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Digestive System Antacids Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Digestive System Antacids Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Digestive System Antacids Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Digestive System Antacids Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Digestive System Antacids Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Digestive System Antacids Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Digestive System Antacids Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Digestive System Antacids Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Digestive System Antacids Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Digestive System Antacids Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Digestive System Antacids Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Digestive System Antacids Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Digestive System Antacids Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Digestive System Antacids Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Digestive System Antacids Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Digestive System Antacids Sales (K Units) by Type (2020-2025)
 Table 51. Global Digestive System Antacids Sales (K Units) by Type (2026-2031)
 Table 52. Global Digestive System Antacids Sales Market Share by Type (2020-2025)
 Table 53. Global Digestive System Antacids Sales Market Share by Type (2026-2031)
 Table 54. Global Digestive System Antacids Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Digestive System Antacids Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Digestive System Antacids Revenue Market Share by Type (2020-2025)
 Table 57. Global Digestive System Antacids Revenue Market Share by Type (2026-2031)
 Table 58. Global Digestive System Antacids Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Digestive System Antacids Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Digestive System Antacids Sales (K Units) by Application (2020-2025)
 Table 61. Global Digestive System Antacids Sales (K Units) by Application (2026-2031)
 Table 62. Global Digestive System Antacids Sales Market Share by Application (2020-2025)
 Table 63. Global Digestive System Antacids Sales Market Share by Application (2026-2031)
 Table 64. Global Digestive System Antacids Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Digestive System Antacids Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Digestive System Antacids Revenue Market Share by Application (2020-2025)
 Table 67. Global Digestive System Antacids Revenue Market Share by Application (2026-2031)
 Table 68. Global Digestive System Antacids Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Digestive System Antacids Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Digestive System Antacids Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Takeda Pharmaceutical Company Information
 Table 76. Takeda Pharmaceutical Description and Business Overview
 Table 77. Takeda Pharmaceutical Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Takeda Pharmaceutical Digestive System Antacids Product
 Table 79. Takeda Pharmaceutical Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Digestive System Antacids Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Reckitt Benckiser Company Information
 Table 86. Reckitt Benckiser Description and Business Overview
 Table 87. Reckitt Benckiser Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Reckitt Benckiser Digestive System Antacids Product
 Table 89. Reckitt Benckiser Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer Digestive System Antacids Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Procter&Gamble Company Information
 Table 96. Procter&Gamble Description and Business Overview
 Table 97. Procter&Gamble Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Procter&Gamble Digestive System Antacids Product
 Table 99. Procter&Gamble Recent Developments/Updates
 Table 100. GlaxoSmithKline Company Information
 Table 101. GlaxoSmithKline Description and Business Overview
 Table 102. GlaxoSmithKline Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline Digestive System Antacids Product
 Table 104. GlaxoSmithKline Recent Developments/Updates
 Table 105. Johnson&Johnson Company Information
 Table 106. Johnson&Johnson Description and Business Overview
 Table 107. Johnson&Johnson Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Johnson&Johnson Digestive System Antacids Product
 Table 109. Johnson&Johnson Recent Developments/Updates
 Table 110. CONBA Company Information
 Table 111. CONBA Description and Business Overview
 Table 112. CONBA Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. CONBA Digestive System Antacids Product
 Table 114. CONBA Recent Developments/Updates
 Table 115. Huasen Pharma Company Information
 Table 116. Huasen Pharma Description and Business Overview
 Table 117. Huasen Pharma Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Huasen Pharma Digestive System Antacids Product
 Table 119. Huasen Pharma Recent Developments/Updates
 Table 120. Sanofi Company Information
 Table 121. Sanofi Description and Business Overview
 Table 122. Sanofi Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sanofi Digestive System Antacids Product
 Table 124. Sanofi Recent Developments/Updates
 Table 125. Bausch Health Company Information
 Table 126. Bausch Health Description and Business Overview
 Table 127. Bausch Health Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Bausch Health Digestive System Antacids Product
 Table 129. Bausch Health Recent Developments/Updates
 Table 130. CR SANJIU Company Information
 Table 131. CR SANJIU Description and Business Overview
 Table 132. CR SANJIU Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. CR SANJIU Digestive System Antacids Product
 Table 134. CR SANJIU Recent Developments/Updates
 Table 135. Reddy'sLaboratories Company Information
 Table 136. Reddy'sLaboratories Description and Business Overview
 Table 137. Reddy'sLaboratories Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Reddy'sLaboratories Digestive System Antacids Product
 Table 139. Reddy'sLaboratories Recent Developments/Updates
 Table 140. Almirall Company Information
 Table 141. Almirall Description and Business Overview
 Table 142. Almirall Digestive System Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Almirall Digestive System Antacids Product
 Table 144. Almirall Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Digestive System Antacids Distributors List
 Table 148. Digestive System Antacids Customers List
 Table 149. Digestive System Antacids Market Trends
 Table 150. Digestive System Antacids Market Drivers
 Table 151. Digestive System Antacids Market Challenges
 Table 152. Digestive System Antacids Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Digestive System Antacids
 Figure 2. Global Digestive System Antacids Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Digestive System Antacids Market Share by Type: 2024 & 2031
 Figure 4. Sodium Bicarbonate Tablets Product Picture
 Figure 5. Magnesium Aluminum Carbonate Tablets Product Picture
 Figure 6. Compound Aluminum Hydroxide Tablets Product Picture
 Figure 7. Aluminum Phosphate Gel Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Digestive System Antacids Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Digestive System Antacids Market Share by Application: 2024 & 2031
 Figure 11. OTC Drug
 Figure 12. Rx Drug
 Figure 13. Global Digestive System Antacids Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Digestive System Antacids Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Digestive System Antacids Sales (2020-2031) & (K Units)
 Figure 16. Global Digestive System Antacids Average Price (US$/Unit) & (2020-2031)
 Figure 17. Digestive System Antacids Report Years Considered
 Figure 18. Digestive System Antacids Sales Share by Manufacturers in 2024
 Figure 19. Global Digestive System Antacids Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Digestive System Antacids Players: Market Share by Revenue in Digestive System Antacids in 2024
 Figure 21. Digestive System Antacids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Digestive System Antacids Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Digestive System Antacids Sales Market Share by Country (2020-2031)
 Figure 24. North America Digestive System Antacids Revenue Market Share by Country (2020-2031)
 Figure 25. United States Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Digestive System Antacids Sales Market Share by Country (2020-2031)
 Figure 28. Europe Digestive System Antacids Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Digestive System Antacids Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Digestive System Antacids Revenue Market Share by Region (2020-2031)
 Figure 36. China Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Digestive System Antacids Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Digestive System Antacids Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Digestive System Antacids Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Digestive System Antacids Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Digestive System Antacids Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Digestive System Antacids by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Digestive System Antacids by Type (2020-2031)
 Figure 57. Global Digestive System Antacids Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Digestive System Antacids by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Digestive System Antacids by Application (2020-2031)
 Figure 60. Global Digestive System Antacids Price (US$/Unit) by Application (2020-2031)
 Figure 61. Digestive System Antacids Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Rare Genetic Disease Diagnosis Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17L15214
Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Non-Invasive Blood Pressure Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2X19545
Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Epidural Anesthesia Sets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Z12895
Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Mobile Applications Melanoma Detection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27A15346
Wed May 28 00:00:00 UTC 2025

Add to Cart

OSZAR »